Skip to content

GLUCOSE HEALTH, INC.: 10-K filed 2014-06-25

What GLUCOSE HEALTH, INC. reported in its annual report filed 2014-06-25 (fiscal FY 2013): 26 published measures, 65 facts as tagged in accession 0001477932-14-003318.

This filing

Form
10-K (annual report)
Filed
2014-06-25
Fiscal period
fiscal FY 2013
Accession
0001477932-14-003318 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All GLUCOSE HEALTH, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2013-12-3125,590USD
At 2012-12-31207,676USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2013-12-31223,348USD
At 2012-12-31185,476USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2013-12-31-197,758USD
At 2012-12-3122,200USD
At 2011-12-31-186,022USD
At 2011-09-30-310,141USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2012-12-311,076USD
At 2011-12-3182USD
At 2011-09-303,929USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2013-01-01 to 2013-12-31-1,459,146USD365
2011-10-01 to 2013-12-31-2,027,796USD823
2012-01-01 to 2012-12-31-399,078USD366

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2013-01-01 to 2013-12-31-131,985USD365
2011-10-01 to 2013-12-31-220,675USD823
2012-01-01 to 2012-12-31-83,691USD366

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2013-01-01 to 2013-12-31131,620USD365
2011-10-01 to 2013-12-31211,950USD823
2012-01-01 to 2012-12-3178,600USD366

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2013-12-31-2,873,925USD
At 2012-12-31-2,873,925USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2013-01-01 to 2013-12-3114,861,248shares365
2012-01-01 to 2012-12-317,605,160shares366

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2013-01-01 to 2013-12-31-0.1USD/shares365
2012-01-01 to 2012-12-31-0.05USD/shares366

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-12-31-1,269,284USD365
2011-10-01 to 2013-12-31-1,801,763USD823
2012-01-01 to 2012-12-31-361,423USD366

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2013-12-3125,590USD
At 2012-12-311,076USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2013-01-01 to 2013-12-31168,862USD365
2011-10-01 to 2013-12-31205,033USD823
2012-01-01 to 2012-12-3137,655USD366

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2013-12-31223,348USD
At 2012-12-31185,476USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2013-01-01 to 2013-12-311,267,193USD365
2011-10-01 to 2013-12-311,796,040USD823
2012-01-01 to 2012-12-31361,423USD366

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2013-12-3124,879USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2013-01-01 to 2013-12-31-2,091USD365
2011-10-01 to 2013-12-31-5,723USD823

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2013-01-01 to 2013-12-312,315USD365
2011-10-01 to 2013-12-315,947USD823

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2013-12-3118,872,777shares
At 2012-12-3110,108,586shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2013-12-31-75,278USD
At 2012-12-31-75,278USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2013-01-01 to 2013-12-31-1,459,146USD365
2011-10-01 to 2013-12-31-2,027,796USD823
2012-01-01 to 2012-12-31-399,078USD366

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2013-01-01 to 2013-12-31-1,459,146USD365
2012-01-01 to 2012-12-31-405,138USD366
2011-10-01 to 2011-12-31-176,090USD92

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2013-01-01 to 2013-12-31-1,459,146USD365
2011-10-01 to 2013-12-31-2,040,374USD823
2012-01-01 to 2012-12-31-405,138USD366

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2013-01-01 to 2013-12-3139,497USD365
2011-10-01 to 2013-12-3145,774USD823
2012-01-01 to 2012-12-315,767USD366

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2013-01-01 to 2013-12-31-189,862USD365
2011-10-01 to 2013-12-31-226,033USD823
2012-01-01 to 2012-12-31-37,655USD366

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-12-3124,879USD365
2011-10-01 to 2013-12-3124,879USD823

Inspect the source

Entity
GLUCOSE HEALTH, INC. / CIK 0001420108
Captured
2026-09-20T08:03:02.532Z
SEC response SHA-256
ef83fc563a3cad26f7c669ccda854bb2594ebf064cf3fcc8412c49070ba2bb26

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001420108.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))